Abstract Psilocybin produces antidepressant effects, but perceptual effects limit tolerability. We hypothesized that enhancing cGMP signaling with a phosphodiesterase-9 inhibitor (PDE9i) would diminish a rodent behavioral readout of 5-HT₂AR activation, while preserving antidepressant-like effects. PDE9i attenuated psilocybin-induced head-twitch while maintaining the antidepressant-like response. PDE9i–psilocybin reduced 5-HT₂AR-related pathways while enhancing synaptogenesis signaling.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with Abigail
Contact Abigail, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack